erlotinib hydrochloride has been researched along with 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) | Trials (4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) | Recent Studies (post-2010) (4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 998 | 15 | 271 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anandharaj, A; Hong, KH; Kassie, F; Kim, JH; Kirtane, AR; Panyam, J; Song, JM; Upadhyaya, P | 1 |
1 other study(ies) available for erlotinib hydrochloride and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
| Article | Year |
|---|---|
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Assay; Biphenyl Compounds; Bronchi; Carcinogenesis; Cell Cycle; Cell Proliferation; Cell Survival; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Female; Lignans; Lung Neoplasms; Magnolia; Mice; Molecular Docking Simulation; Nitrosamines; Plant Extracts; RNA, Small Interfering | 2016 |